Radiomics approach for preoperative identification of stages I-II and III-IV of esophageal cancer

被引:48
|
作者
Wu, Lei [1 ,2 ]
Wang, Cong [3 ]
Tan, Xianzheng [2 ]
Cheng, Zixuan [1 ,2 ]
Zhao, Ke [1 ,2 ]
Yan, Lifen [2 ]
Liang, Yanli [2 ]
Liu, Zaiyi [2 ]
Liang, Changhong [1 ,2 ]
机构
[1] South China Univ Technol, Sch Med, Guangzhou 510006, Guangdong, Peoples R China
[2] Guangdong Gen Hosp, Guangdong Acad Med Sci, Dept Radiol, 106 Zhongshan Er Rd, Guangzhou 510080, Guangdong, Peoples R China
[3] South China Univ Technol, Sch Automat Sci & Engn, Guangzhou 510641, Guangdong, Peoples R China
基金
国家重点研发计划;
关键词
Esophageal cancer; tumor staging; diagnostic imaging; tumor volume; POSITRON-EMISSION-TOMOGRAPHY; TEXTURE ANALYSIS; MULTIMARKER ANALYSIS; COMPUTED-TOMOGRAPHY; ESOPHAGOGASTRIC JUNCTION; TUMOR HETEROGENEITY; PROGNOSTIC-FACTORS; CT; REGRESSION; MRI;
D O I
10.21147/j.issn.1000-9604.2018.04.02
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To predict preoperative staging using a radiomics approach based on computed tomography (CT) images of patients with esophageal squamous cell carcinoma (ESCC). Methods: This retrospective study included 154 patients (primary cohort: n=114; validation cohort: n=40) with pathologically confirmed ESCC. All patients underwent a preoperative CT scan from the neck to abdomen. High throughput and quantitative radiomics features were extracted from the CT images for each patient. A radiomics signature was constructed using the least absolute shrinkage and selection operator (Lasso). Associations between radiomics signature, tumor volume and ESCC staging were explored. Diagnostic performance of radiomics approach and tumor volume for discriminating between stages I-II and III-IV was evaluated and compared using the receiver operating characteristics (ROC) curves and net reclassification improvement (NRI). Results: A total of 9,790 radiomics features were extracted. Ten features were selected to build a radiomics signature after feature dimension reduction. The radiomics signature was significantly associated with ESCC staging (P<0.001), and yielded a better performance for discrimination of early and advanced stage ESCC compared to tumor volume in both the primary [area under the receiver operating characteristic curve (AUC): 0.795 vs. 0.694, P=0.003; NRI=0.424)] and validation cohorts (AUC: 0.762 vs. 0.624, P=0.035; NRI=0.834). Conclusions: The quantitative approach has the potential to identify stage I-II and III-IV ESCC before treatment.
引用
收藏
页码:396 / +
页数:14
相关论文
共 50 条
  • [21] The effect of digital acupressure on chemotherapy-induced nausea in Indonesian patients with stages III-IV breast cancer
    Wicaksono, Beni
    Hadian, Feriana Ira
    Ulhaq, Zulvikar Syambani
    JOURNAL OF AYURVEDA AND INTEGRATIVE MEDICINE, 2023, 14 (05)
  • [22] Transcriptome meta-analysis reveals differences of immune profile between eutopic endometrium from stage I-II and III-IV endometriosis independently of hormonal milieu
    Poli-Neto, Omero Benedicto
    Meola, Juliana
    Rosa-e-Silva, Julio Cesar
    Tiezzi, Daniel
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [23] Prospects for studying the E-cadherin level in tumors of patients having ovarian cancer of III-IV stages
    Knyazyeva, M.
    Prokopyuk, A.
    Shus, A.
    FEBS OPEN BIO, 2021, 11 : 418 - 418
  • [24] The content of glycosaminoglycans (GAG) as part of a diagnostic complex evaluation of treatment effect in ovarian cancer stages III-IV
    Maryna, V. Knyazyeva
    Alexandra, V. Prokopyuk
    Tamara, D. Pavlova
    FEBS JOURNAL, 2010, 277 : 198 - 198
  • [25] Synchronously occurring lung cancer (stages I-II) and coronary artery disease: Concomitant versus staged surgical approach
    Voets, AJ
    Joesoef, KS
    van Teeffelen, MEJM
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1997, 12 (05) : 713 - 717
  • [26] Surgery and chemotherapy for small cell lung cancer in stages I-II with or without radiotherapy
    Bischof, Marc
    Debus, Juergen
    Herfarth, Klaus
    Muley, Thomas
    Kappes, Jutta
    Storz, Konstantina
    Hoffmann, Hans
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 (12) : 679 - 684
  • [27] Research Prognostic evaluation of esophageal cancer patients with stages I-III
    Qiu, Meng-jun
    Yang, Sheng-li
    Wang, Meng-meng
    Li, Ya-nan
    Jiang, Xin
    Huang, Zao-zao
    Xiong, Zhi-fan
    AGING-US, 2020, 12 (14): : 14736 - 14753
  • [28] IV DICHLOROMETHYLENE DIPHOSPHONATE IN CANCER-ASSOCIATED HYPERCALCEMIA - A PHASE I-II EVALUATION
    COHEN, AI
    KOELLER, J
    DAVIS, TE
    CITRIN, DL
    CANCER TREATMENT REPORTS, 1981, 65 (7-8): : 651 - 653
  • [29] Surgical and Oncological Outcomes of Level III-IV Versus Level I-II Inferior Vena Cava Thrombectomy: A Decennial Experience of a High-Volume European Referral Center
    Dell'Oglio, Paolo
    Tappero, Stefano
    Mandelli, Giuditta
    Saccucci, Tommaso
    Dibilio, Edoardo
    Caviglia, Alberto
    Vecchio, Enrico
    Maltzman, Ofir
    Martiriggiano, Marco
    Olivero, Alberto
    Secco, Silvia
    Barbieri, Michele
    Di Trapani, Dario
    Buratto, Carlo
    Palagonia, Erika
    Strada, Elena
    Napoli, Giancarlo
    Petralia, Giovanni
    Bocciardi, Aldo Massimo
    Galfano, Antonio
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (12) : 8383 - 8393
  • [30] Preoperative Serum C-Reactive Protein and its Prognostic Significance in Patients with Stage III-IV Colorectal Cancer
    Lumachi, Franco
    Basso, Stefano M. M.
    Santeufemia, Davide A.
    Ermani, Mario
    Lo Re, Giovanni
    Chiara, Giordano B.
    ANTICANCER RESEARCH, 2014, 34 (12) : 7263 - 7266